Related Experiment Video
Updated: Mar 7, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Present Day Anti-viral Therapy in Dermatology
Abstract:
Attempts to develop drugs for the prevention and treatment of viral infections have faced variety of problems different firom those encoun'tered in the development of other type of antimicrobial agents. There are difficulties and consequently slow progress in the discovery of drugs which inhibit viral growth. Viruses have to strictly depend on living cells for replication. The narrow margin between the therapeutic dose of antiviral agents and lethal dose to the cells themselves is one of the major problems encountered in the development of viricidal drugs. Present day therapy in viral diseases is discussed in this paper with a review of the literature.
Related Concept Videos
Retrovirus Life Cycles
Subviral Agents
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Retroviruses
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hand hygiene
Hand washing...

